Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;5(7):e2221982.
doi: 10.1001/jamanetworkopen.2022.21982.

Association of Mediterranean Diet With Cognitive Decline Among Diverse Hispanic or Latino Adults From the Hispanic Community Health Study/Study of Latinos

Affiliations

Association of Mediterranean Diet With Cognitive Decline Among Diverse Hispanic or Latino Adults From the Hispanic Community Health Study/Study of Latinos

Bayan Moustafa et al. JAMA Netw Open. .

Abstract

Importance: The Mediterranean diet may reduce the burden of Alzheimer disease and other associated dementias in Hispanic or Latino people.

Objective: To investigate the association of a Mediterranean diet with cognitive performance among community-dwelling Hispanic or Latino adults.

Design, setting, and participants: This cohort study analyzed data from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA), an HCHS/SOL ancillary study. Cognition tests were administered in the HCHS/SOL from March 2008 to June 2011 (visit 1) and in the SOL-INCA from October 2015 to March 2018 (visit 2). Participants included in the present study had completed a diet assessment at visit 1 and neurocognitive evaluations at visits 1 and 2. Data were analyzed from September 2021 to May 2022.

Exposures: Mediterranean diet adherence was ascertained using the Mediterranean diet score (MDS) and was categorized as low (MDS: 0-4 points), moderate (MDS: 5-6 points), or high (MDS: 7-9 points). The mean of two 24-hour dietary recalls was used to calculate the MDS.

Main outcomes and measures: Cognitive change between visits 1 and 2 was calculated by subtracting the cognitive score at visit 2 from the cognitive score at visit 1 and adjusting by the time elapsed between visits and cognitive score at visit 1. Neurocognitive tests administered were Brief Spanish-English Verbal Learning Test (B-SEVLT) Sum, B-SEVLT Recall, word fluency, and Digit Symbol Substitution Test (DSST). Results of each test were z score-transformed and the means were averaged to create a global cognition score. Complex sample linear regression analysis was used to ascertain the association between MDS and neurocognitive performance at each visit and neurocognitive change.

Results: A total of 6321 participants (mean [SE] age, 56.1 [0.18] years at visit 1; n = 4077 women [57.8%]) were included. Mediterranean diet adherence weighted frequencies were 35.8% (n = 2112 of 6321) for the low adherence group, 45.4% (n = 2795) for the moderate adherence group, and 18.8% (n = 1414) for the high adherence group. In the fully adjusted model, z score-transformed cognitive scores at visit 1 in the high vs low adherence groups were higher for B-SEVLT Sum (β = 0.11; 95% CI, 0.02-0.20), B-SEVLT Recall (β = 0.16; 95% CI, 0.07-0.25), and global cognition (β = 0.10; 95% CI, 0.04-0.16) tests. In the mean follow-up time of 7 years, cognitive change in the high vs low adherence groups was less pronounced for B-SEVLT Sum (β = 0.12; 95% CI, 0.05-0.20) and B-SEVLT Recall (β = 0.14; 95% CI, 0.05-0.23), but not for word fluency, DSST score, or global cognition score.

Conclusions and relevance: Results of this cohort study suggested that high adherence to a Mediterranean diet was associated with better cognitive performance and decreased 7-year learning and memory decline among middle-aged and older Hispanic or Latino adults. Culturally tailored Mediterranean diet may reduce the risk of cognitive decline and Alzheimer disease in this population.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Lipton reported receiving personal fees from Abbvie (Allergan), American Academy of Neurology, American Headache Society, Amgen, Avanir, Axsome, Biohaven, BioVision, Boston Scientific, Ctrl M Health, Dr Reddy’s Laboratories (Promius), electroCore, Eli Lilly, eNeura Therapeutics, Equinox, GlaxoSmithKline, Grifols, Lundbeck (Alder), Merck, Pernix, Pfizer, Satsuma, Supernus, Teva Pharmaceuticals, Trigemina, Vector, and Vedanta outside the submitted work; receiving grants from Amgen, Teva Pharmaceuticals, Satsuma, and National Institutes of Health (NIH); being the Edwin S. Lowe Professor of Neurology at the Albert Einstein College of Medicine in New York; receiving support from the Migraine Research Foundation and the National Headache Foundation; serving on the editorial board of Neurology, as senior advisor to Headache, and as associate editor to Cephalalgia; being a reviewer for the National Institute on Aging (NIA) and National Institute of Neurological Disorders and Stroke; holding stock options in Biohaven Holdings and CtrlM Health; and receiving royalties from Oxford University Press, Wiley, and Informa. Dr Mattei reported receiving grants from the NIH and Robert Wood Johnson Foundation outside the submitted work. Dr Testai reported receiving private donation from Louis and Christine Friedrich. No other disclosures were reported.

Comment in

Similar articles

Cited by

References

    1. Livingston G, Huntley J, Sommerlad A, et al. . Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446. doi:10.1016/S0140-6736(20)30367-6 - DOI - PMC - PubMed
    1. US Department of Health and Human Services, Administration for Community Living. 2019 Profile of older Americans. 2020. Accessed October 17, 2021. https://acl.gov/aging-and-disability-in-america/data-and-research/profil...
    1. Alzheimer’s Association . Alzheimer's disease facts and figures. Race, ethnicity and Alzheimer’s in America: special report. 2021. Accessed October 18, 2021. https://www.alz.org/alzheimers-dementia/facts-figures
    1. Wu S, Vega W, Resendez J, Jin H. Latinos and Alzheimer’s disease: new numbers behind the crisis. USC Edward R. Roybal Institute on Aging and the Latinos Against Alzheimer’s Network. 2016. Accessed April 25, 2022. https://health.ucdavis.edu/latinoaging/news/pdf/Latinos_and_AD_USC_UsA2-...
    1. Mooldijk SS, Licher S, Wolters FJ. Characterizing demographic, racial, and geographic diversity in dementia research: a systematic review. JAMA Neurol. 2021;78(10):1255-1261. doi:10.1001/jamaneurol.2021.2943 - DOI - PubMed

Publication types